Medical Director

Member of the American Urologic Association since 1985
Member of the National Institutes of Health (NIH) “Prostatitis Collaborative”
Internationally known Urologist invited to speak at the 1st National Men’s Health Conference sponsored by Penn State (May 21, 2004); Topic: “Can Education and Awareness on Prostate Disease Alter the Death Rate from Prostate Cancer in the State of Florida?”
Practicing Urologist for more than 20 years with practice focus on male health related issues including Impotency and Prostate Diseases associated with BPH, Prostatitis, and Prostate Cancer
Participant Physician in a Vaccine Study (sponsor: Dendreon) for Hormone Refractive Prostate Cancer utilizing “Provenge”
Member of the Advisory Board For Several Health-Related Corporations and Foundations including: Sanofi-Aventis Oncology, Urology Times, PAACT, Prostate Awareness Foundation, Glaxo Smith Kline, Abbott, and Radiation Centers of America
Medical Director of the Diagnostic Center for Disease™ located in Sarasota, Florida, featuring 3.0 T MRI-Spectroscopy, “the next greatest diagnostic test for prostate cancer”, according to Peter Scardino, M.D. from Memorial Sloan-Kettering; this technology helps men to avoid unnecessary prostate biopsies
Certified expert in High Intensity Focused Ultrasound (HIFU), a novel prostate cancer treatment, that is currently involved in Phase 3 trials at the FDA; this therapy is currently available in Canada, Dominican Republic, Mexico and the Bahamas
Medical Director of Preferred Health Foundation … speaking to better choices in health care through awareness and education
Runner-up in the “Physician Educator of the Year” award sponsored by AFUD (American Foundation of Urologic Disease)
Post Graduate 3T MRI Educational Symposia: Why and What You Need to Know About 3T MRI – Sponsored by General Electric (March, 2007)
Post Graduate MRI-S Physician Review Course Sponsored by UCSF – December, 2006
Principal Investigator in a “Neo-Adjuvant Study for Organ Confined Prostate Cancer”, sponsored in part by Schering Pharmaceuticals and accepted for presentation at the Western Section of the American Urology Association (AUA)
Owner of two Patents on Prostatitis Detection and Resolution; Prostatitis is a Precursor disease process known to evolve into Prostate Cancer (reference: American Association of Cancer Research; AACR)
Invited Speaker at the National Institutes of Health (Bethesda, Maryland) in 1999 and 2000 discussing the topics of: “Voiding Symptoms Predict Prostatitis, Not BPH” and “For the Prostate to be Healthy, Your PSA Must Be Less than One”
Featured Speaker at the American College of Advanced Medicine (ACAM), November 2002 & October 2008
Featured Speaker at Age Management Medicine Group (AMMG), November 2008
Featured Speaker at the Cancer Control Society, September 2003 on “Prostatitis as a Cause of Prostate Cancer and why the PSA (blood test) Must be Less than One”